Cargando…
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
Cell cycle dysregulation is a characteristic hallmark of malignancies, which results in uncontrolled cell proliferation and eventual tumor formation. Cyclin-dependent kinase 1 (CDK1) is a member of the family of cell cycle regulatory proteins involved in cell cycle maintenance. Given that overexpres...
Autores principales: | Sofi, Shazia, Mehraj, Umar, Qayoom, Hina, Aisha, Shariqa, Almilaibary, Abdullah, Alkhanani, Mustfa, Mir, Manzoor Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207877/ https://www.ncbi.nlm.nih.gov/pubmed/35723742 http://dx.doi.org/10.1007/s12032-022-01748-2 |
Ejemplares similares
-
Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation
por: sofi, Shazia, et al.
Publicado: (2023) -
Mechanistic elucidation of Juglanthraquinone C targeting breast Cancer: A network Pharmacology-based investigation
por: Qayoom, Hina, et al.
Publicado: (2023) -
Decoding the molecular mechanism of stypoldione against breast cancer through network pharmacology and experimental validation
por: Qayoom, Hina, et al.
Publicado: (2023) -
Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941
por: Mehraj, Umar, et al.
Publicado: (2022) -
Molecular docking analysis and evaluation of the antimicrobial properties of the constituents of Geranium wallichianum D. Don ex Sweet from Kashmir Himalaya
por: Mir, Wajahat Rashid, et al.
Publicado: (2022)